Home›Trial›NCT06655870
🔬NCT06655870Phase 1ACTIVE NOT RECRUITING

A Study to Investigate Safety and Tolerability of mRNA-0184 Administered Subcutaneously in Healthy Participants

Study Summary

The purpose of this study is to test the safety of mRNA-0184 in healthy participants.

Conditions
Healthy Participants
Interventions / Drugs
mRNA-0184
View on ClinicalTrials.gov ↗
Sponsor
MRNA
Moderna Inc
mRNA Therapeutics
C53/100
Study Details
Enrollment52 participants
Primary Completion—
Lead SponsorModernaTX, Inc.
Data Retrieved2026-04-11 02:55:38.209322+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.